LEMAITRE VASCULAR, INC. Operating Lease, Payments
LEMAITRE VASCULAR, INC. (LMAT) reported Operating Lease, Payments of $3.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. operating lease, payments for the quarter ending 2025-03-31 was $876.00K, a 14.29% decline year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, payments for the quarter ending 2024-12-31 was $1.23M, a 74.79% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, payments for the quarter ending 2024-09-30 was $758.00K, a 21.61% decline year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, payments for the quarter ending 2024-06-30 was $977.00K, a 34.02% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, payments for fiscal 2025 was $3.61M, a 9.52% decline from fiscal 2024.
- LEMAITRE VASCULAR, INC. operating lease, payments for fiscal 2024 was $3.99M, a 27.14% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. operating lease, payments for fiscal 2023 was $3.14M, a 9.07% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. operating lease, payments for fiscal 2022 was $2.88M, a 0.66% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.61M 10-K · filed 2026-02-26 | |||
| 2025-03-31 | $876.00K 10-Q · filed 2025-05-08 | $2.11M derived: sum of 2 quarters · filed 2026-02-26 | $2.87M derived: sum of 3 quarters · filed 2026-02-26 | $3.85M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.99M derived: sum of 2 quarters · filed 2026-02-26 | $2.97M derived: sum of 3 quarters · filed 2026-02-26 | $3.99M 10-K · filed 2026-02-26 |
| 2024-09-30 | $758.00K 10-Q · filed 2024-11-08 | $1.74M derived: sum of 2 quarters · filed 2024-11-08 | $2.76M 10-Q · filed 2024-11-08 | $3.46M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-06-30 | $977.00K 10-Q · filed 2024-08-08 | $2.00M 10-Q · filed 2024-08-08 | $2.71M derived: sum of 3 quarters · filed 2025-05-08 | $3.67M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $1.02M 10-Q · filed 2025-05-08 | $1.73M derived: sum of 2 quarters · filed 2025-05-08 | $2.69M derived: sum of 3 quarters · filed 2025-05-08 | $3.42M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.67M derived: sum of 2 quarters · filed 2025-02-28 | $2.40M derived: sum of 3 quarters · filed 2025-02-28 | $3.14M 10-K · filed 2025-02-28 |
| 2023-09-30 | $967.00K 10-Q · filed 2024-11-08 | $1.70M derived: sum of 2 quarters · filed 2024-11-08 | $2.43M 10-Q · filed 2024-11-08 | $2.85M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $729.00K 10-Q · filed 2024-08-08 | $1.47M 10-Q · filed 2024-08-08 | $1.88M derived: sum of 3 quarters · filed 2024-08-08 | $2.86M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $737.00K 10-Q · filed 2024-05-10 | $1.15M derived: sum of 2 quarters · filed 2024-05-10 | $2.13M derived: sum of 3 quarters · filed 2024-05-10 | $2.94M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.39M derived: sum of 2 quarters · filed 2024-02-29 | $2.20M derived: sum of 3 quarters · filed 2024-02-29 | $2.88M 10-K · filed 2024-02-29 |
| 2022-09-30 | $977.00K 10-Q · filed 2023-11-07 | $1.79M derived: sum of 2 quarters · filed 2023-11-07 | $2.46M 10-Q · filed 2023-11-07 | $3.21M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $810.00K 10-Q · filed 2023-08-08 | $1.48M 10-Q · filed 2023-08-08 | $2.24M derived: sum of 3 quarters · filed 2023-08-08 | $2.96M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $674.00K 10-Q · filed 2023-05-09 | $1.43M derived: sum of 2 quarters · filed 2023-05-09 | $2.15M derived: sum of 3 quarters · filed 2023-05-09 | $2.79M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.48M derived: sum of 2 quarters · filed 2023-03-01 | $2.11M derived: sum of 3 quarters · filed 2023-03-01 | $2.86M 10-K · filed 2023-03-01 |
| 2021-09-30 | $725.00K 10-Q · filed 2022-11-08 | $1.36M derived: sum of 2 quarters · filed 2022-11-08 | $2.11M 10-Q · filed 2022-11-08 | $2.75M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $633.00K 10-Q · filed 2022-08-05 | $1.38M 10-Q · filed 2022-08-05 | $2.02M derived: sum of 3 quarters · filed 2022-08-05 | $2.61M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $748.00K 10-Q · filed 2022-05-10 | $1.39M derived: sum of 2 quarters · filed 2022-05-10 | $1.98M derived: sum of 3 quarters · filed 2022-05-10 | $2.56M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $643.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.23M derived: sum of 2 quarters · filed 2022-02-28 | $1.81M derived: sum of 3 quarters · filed 2022-02-28 | $2.40M 10-K · filed 2022-02-28 |
| 2020-09-30 | $590.00K 10-Q · filed 2021-11-04 | $1.17M derived: sum of 2 quarters · filed 2021-11-04 | $1.76M 10-Q · filed 2021-11-04 | $2.16M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $580.00K 10-Q · filed 2021-08-05 | $1.17M 10-Q · filed 2021-08-05 | $1.57M derived: sum of 3 quarters · filed 2021-08-05 | $2.07M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $591.00K 10-Q · filed 2021-05-10 | $992.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.49M derived: sum of 3 quarters · filed 2021-05-10 | $1.94M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $899.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.34M derived: sum of 3 quarters · filed 2021-03-12 | $1.86M 10-K · filed 2021-03-12 |
| 2019-09-30 | $498.00K 10-Q · filed 2020-11-06 | $943.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.46M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $445.00K 10-Q · filed 2020-08-06 | $959.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $514.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |